8-KLeadership Changes

Air Products & Chemicals, Inc. 8-K Report, Executive Changes (Jul 22, 2024)

Filed July 22, 2024For Securities:APD

Summary

Air Products & Chemicals, Inc. (APD) announced the immediate resignation of Dr. Samir J. Serhan as Chief Operating Officer (COO) on July 18, 2024. While Dr. Serhan is stepping down from his COO role, he is expected to continue with the company in a transitional capacity until September 30, 2024. This transition will be governed by the Company's Executive Separation Program, the details of which were previously disclosed in its 2024 proxy statement. Investors should monitor how this executive departure impacts operational leadership and strategic execution, although the company has indicated adherence to established separation protocols. The company has not provided further details regarding the reasons for Dr. Serhan's departure or immediate plans for appointing a successor for the COO position.

Key Highlights

  • 1Dr. Samir J. Serhan has resigned as Chief Operating Officer (COO) of Air Products & Chemicals, Inc., effective immediately.
  • 2Dr. Serhan will remain with the company until September 30, 2024, in a transitional capacity.
  • 3His departure and associated benefits will be managed under the Company’s Executive Separation Program.
  • 4The terms of the Executive Separation Program were previously disclosed in the Company's 2024 Annual Meeting of Stockholders' proxy statement filed on December 8, 2023.
  • 5The 8-K filing does not specify the reasons for Dr. Serhan's resignation.

Frequently Asked Questions

Dr. Samir J. Serhan has resigned as Chief Operating Officer (COO). While he will remain with the company until September 30, 2024, to assist with the transition, his departure from the COO role is immediate. Investors may want to observe leadership changes and operational continuity.

Dr. Serhan is expected to receive severance and other benefits in accordance with the Company’s Executive Separation Program. The specific financial details of this program were previously disclosed in Air Products' 2024 proxy statement, and this 8-K filing does not provide new financial terms.

This 8-K filing does not mention the appointment of a successor for the Chief Operating Officer position. Investors should look for future announcements regarding leadership roles.

The Executive Separation Program is a pre-established company policy that outlines the terms and benefits provided to executives upon their departure from the company. The specific terms for Dr. Serhan will be governed by this program, the details of which were disclosed in Air Products' 2024 proxy statement filed on December 8, 2023.